These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 10700145)
1. Effects in live cells of a c-myc anti-gene PNA linked to a nuclear localization signal. Cutrona G; Carpaneto EM; Ulivi M; Roncella S; Landt O; Ferrarini M; Boffa LC Nat Biotechnol; 2000 Mar; 18(3):300-3. PubMed ID: 10700145 [TBL] [Abstract][Full Text] [Related]
2. Dihydrotestosterone as a selective cellular/nuclear localization vector for anti-gene peptide nucleic acid in prostatic carcinoma cells. Boffa LC; Scarfi S; Mariani MR; Damonte G; Allfrey VG; Benatti U; Morris PL Cancer Res; 2000 Apr; 60(8):2258-62. PubMed ID: 10786693 [TBL] [Abstract][Full Text] [Related]
3. Lack of mutagenicity and clastogenicity of PNAEmu-NLS targeted to a regulatory sequence of the translocated c-myc oncogene in Burkitt's lymphoma. Boffa LC; Menichini P; Bolognesi C; Cutrona G; Roncella S; Damonte GL; Millo E; Mariani MR; Matis S; Russo D; Ciliutti P; Ferrarini M Mutat Res; 2007 Apr; 628(2):129-37. PubMed ID: 17267263 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of the translocated c-myc in Burkitt's lymphoma by a PNA complementary to the E mu enhancer. Cutrona G; Carpaneto EM; Ponzanelli A; Ulivi M; Millo E; Scarfì S; Roncella S; Benatti U; Boffa LC; Ferrarini M Cancer Res; 2003 Oct; 63(19):6144-8. PubMed ID: 14559793 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of Burkitt's lymphoma cells growth in SCID mice by a PNA specific for a regulatory sequence of the translocated c-myc. Boffa LC; Cutrona G; Cilli M; Matis S; Damonte G; Mariani MR; Millo E; Moroni M; Roncella S; Fedeli F; Ferrarini M Cancer Gene Ther; 2007 Feb; 14(2):220-6. PubMed ID: 17053816 [TBL] [Abstract][Full Text] [Related]
6. Targeted inhibition of NMYC by peptide nucleic acid in N-myc amplified human neuroblastoma cells: cell-cycle inhibition with induction of neuronal cell differentiation and apoptosis. Pession A; Tonelli R; Fronza R; Sciamanna E; Corradini R; Sforza S; Tedeschi T; Marchelli R; Montanaro L; Camerin C; Franzoni M; Paolucci G Int J Oncol; 2004 Feb; 24(2):265-72. PubMed ID: 14719101 [TBL] [Abstract][Full Text] [Related]
7. A peptide nucleic acid-nuclear localization signal fusion that mediates nuclear transport of DNA. Brandén LJ; Mohamed AJ; Smith CI Nat Biotechnol; 1999 Aug; 17(8):784-7. PubMed ID: 10429244 [TBL] [Abstract][Full Text] [Related]
8. Reduction of c-myc expression by an antisense approach under Cre/loxP switching induces apoptosis in human liver cancer cells. Ebinuma H; Saito H; Kosuga M; Wakabayashi K; Saito Y; Takagi T; Nakamoto N; Okuyama T; Ishii H J Cell Physiol; 2001 Jul; 188(1):56-66. PubMed ID: 11382922 [TBL] [Abstract][Full Text] [Related]
9. Circular dichroism study of DNA binding by a potential anticancer peptide nucleic acid targeted against the MYCN oncogene. Faccini A; Tortori A; Tedeschi T; Sforza S; Tonelli R; Pession A; Corradini R; Marchelli R Chirality; 2008 Mar; 20(3-4):494-500. PubMed ID: 17963203 [TBL] [Abstract][Full Text] [Related]
10. Interference of mouse polyomavirus with the c-myc gene and its product in mouse mammary adenocarcinomas. Holländerová D; Raslová H; Blangy D; Forstová J; Berebbi M Int J Oncol; 2003 Aug; 23(2):333-41. PubMed ID: 12851682 [TBL] [Abstract][Full Text] [Related]
11. Induced p21WAF1 expression acts to reverse myc myelomonocytic cell transformation. Dolnikov A; Millington M; Sun LQ; Symonds G Cancer Gene Ther; 2000 Nov; 7(11):1491-503. PubMed ID: 11129291 [TBL] [Abstract][Full Text] [Related]
12. Anti-CD20- and B-cell receptor-mediated apoptosis: evidence for shared intracellular signaling pathways. Mathas S; Rickers A; Bommert K; Dörken B; Mapara MY Cancer Res; 2000 Dec; 60(24):7170-6. PubMed ID: 11156427 [TBL] [Abstract][Full Text] [Related]
13. Transcription inhibition of oncogenic KRAS by a mutation-selective peptide nucleic acid conjugated to the PKKKRKV nuclear localization signal peptide. Cogoi S; Codognotto A; Rapozzi V; Meeuwenoord N; van der Marel G; Xodo LE Biochemistry; 2005 Aug; 44(31):10510-9. PubMed ID: 16060660 [TBL] [Abstract][Full Text] [Related]
14. c-myc Suppression in Burkitt's lymphoma cells. Simonsson T; Henriksson M Biochem Biophys Res Commun; 2002 Jan; 290(1):11-5. PubMed ID: 11779125 [TBL] [Abstract][Full Text] [Related]
15. Contrasting effects of PNA invasion of the chimeric DMMYC gene on transcription of its myc and PVT domains. Boffa LC; Carpaneto EM; Mariani MR; Louissaint M; Allfrey VG Oncol Res; 1997; 9(1):41-51. PubMed ID: 9112259 [TBL] [Abstract][Full Text] [Related]
16. Hypoxia promotes apoptosis of human neuroblastoma cell lines with enhanced N-myc expression. Rössler J; Schwab M; Havers W; Schweigerer L Biochem Biophys Res Commun; 2001 Feb; 281(2):272-6. PubMed ID: 11181040 [TBL] [Abstract][Full Text] [Related]
17. Antisense c-myc fragments induce normal differentiation cycles in HL-60 cells. Chen JP; Chen L; Leek J; Lin C Eur J Clin Invest; 2006 Jan; 36(1):49-57. PubMed ID: 16403010 [TBL] [Abstract][Full Text] [Related]
18. PNAEmu can significantly reduce Burkitt's lymphoma tumor burden in a SCID mice model: cells dissemination similar to the human disease. Matis S; Mariani MR; Cutrona G; Cilli M; Piccardi F; Daga A; Damonte G; Millo E; Moroni M; Roncella S; Fedeli F; Boffa LC; Ferrarini M Cancer Gene Ther; 2009 Oct; 16(10):786-93. PubMed ID: 19363465 [TBL] [Abstract][Full Text] [Related]
19. c-myc down-regulation induces apoptosis in human cancer cell lines exposed to RPR-115135 (C31H29NO4), a non-peptidomimetic farnesyltransferase inhibitor. Russo P; Arzani D; Trombino S; Falugi C J Pharmacol Exp Ther; 2003 Jan; 304(1):37-47. PubMed ID: 12490573 [TBL] [Abstract][Full Text] [Related]
20. Iron specific growth inhibition of Burkitt's lymphoma cells in vitro, associated with a decrease in translocated c-myc expression. Habel ME; Lemieux R; Jung D J Cell Physiol; 2005 Apr; 203(1):277-85. PubMed ID: 15468060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]